Cholesterol Testing Products Market Size to Hit USD 50.15 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cholesterol Testing Products Market

5.1. COVID-19 Landscape: Cholesterol Testing Products Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cholesterol Testing Products Market, By Product Type

8.1. Cholesterol Testing Products Market Revenue and Volume, by Product Type

8.1.1. Test Kits & Reagents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Cholesterol Analyzers

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cholesterol Test Strips

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Lipid Profile Panels

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Lancets & Capillary Tubes

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Cholesterol Testing Products Market, By Test Type

9.1. Cholesterol Testing Products Market Revenue and Volume, by Test Type

9.1.1. Total Cholesterol Test

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. High-Density Lipoprotein (HDL) Test

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Low-Density Lipoprotein (LDL) Test

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Triglycerides Test

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Comprehensive Lipid Panel (CLP)

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Cholesterol Testing Products Market, By Mode of Testing

10.1. Cholesterol Testing Products Market Revenue and Volume, by Mode of Testing

10.1.1. Home-Based Testing

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Point-of-Care Testing (POCT)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Laboratory-Based Testing

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Cholesterol Testing Products Market, By End User

11.1. Cholesterol Testing Products Market Revenue and Volume, by End User

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Home Care Settings

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Research Institutes & CROs

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Cholesterol Testing Products Market, By Distribution Channel

12.1. Cholesterol Testing Products Market Revenue and Volume, by Distribution Channel

12.1.1. Retail Pharmacies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Hospital Pharmacies

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Online Pharmacies

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Direct Sales (B2B)

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Cholesterol Testing Products Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Test Type

13.1.3. Market Revenue and Volume Forecast, by Mode of Testing

13.1.4. Market Revenue and Volume Forecast, by End User

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Test Type

13.1.6.3. Market Revenue and Volume Forecast, by Mode of Testing

13.1.6.4. Market Revenue and Volume Forecast, by End User

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Test Type

13.1.7.3. Market Revenue and Volume Forecast, by Mode of Testing

13.1.7.4. Market Revenue and Volume Forecast, by End User

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Test Type

13.2.3. Market Revenue and Volume Forecast, by Mode of Testing

13.2.4. Market Revenue and Volume Forecast, by End User

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Test Type

13.2.6.3. Market Revenue and Volume Forecast, by Mode of Testing

13.2.7. Market Revenue and Volume Forecast, by End User

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Test Type

13.2.9.3. Market Revenue and Volume Forecast, by Mode of Testing

13.2.10. Market Revenue and Volume Forecast, by End User

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Test Type

13.2.12.3. Market Revenue and Volume Forecast, by Mode of Testing

13.2.12.4. Market Revenue and Volume Forecast, by End User

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Test Type

13.2.14.3. Market Revenue and Volume Forecast, by Mode of Testing

13.2.14.4. Market Revenue and Volume Forecast, by End User

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Test Type

13.3.3. Market Revenue and Volume Forecast, by Mode of Testing

13.3.4. Market Revenue and Volume Forecast, by End User

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Test Type

13.3.6.3. Market Revenue and Volume Forecast, by Mode of Testing

13.3.6.4. Market Revenue and Volume Forecast, by End User

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Test Type

13.3.8.3. Market Revenue and Volume Forecast, by Mode of Testing

13.3.8.4. Market Revenue and Volume Forecast, by End User

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Test Type

13.3.10.3. Market Revenue and Volume Forecast, by Mode of Testing

13.3.10.4. Market Revenue and Volume Forecast, by End User

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Test Type

13.3.11.3. Market Revenue and Volume Forecast, by Mode of Testing

13.3.11.4. Market Revenue and Volume Forecast, by End User

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Test Type

13.4.3. Market Revenue and Volume Forecast, by Mode of Testing

13.4.4. Market Revenue and Volume Forecast, by End User

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Test Type

13.4.6.3. Market Revenue and Volume Forecast, by Mode of Testing

13.4.6.4. Market Revenue and Volume Forecast, by End User

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Test Type

13.4.8.3. Market Revenue and Volume Forecast, by Mode of Testing

13.4.8.4. Market Revenue and Volume Forecast, by End User

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Test Type

13.4.10.3. Market Revenue and Volume Forecast, by Mode of Testing

13.4.10.4. Market Revenue and Volume Forecast, by End User

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Test Type

13.4.11.3. Market Revenue and Volume Forecast, by Mode of Testing

13.4.11.4. Market Revenue and Volume Forecast, by End User

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Test Type

13.5.3. Market Revenue and Volume Forecast, by Mode of Testing

13.5.4. Market Revenue and Volume Forecast, by End User

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Test Type

13.5.6.3. Market Revenue and Volume Forecast, by Mode of Testing

13.5.6.4. Market Revenue and Volume Forecast, by End User

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Test Type

13.5.8.3. Market Revenue and Volume Forecast, by Mode of Testing

13.5.8.4. Market Revenue and Volume Forecast, by End User

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Roche Diagnostics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens Healthineers

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Danaher Corporation (Beckman Coulter)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Thermo Fisher Scientific

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Randox Laboratories

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nova Biomedical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. PTS Diagnostics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. ACON Laboratories

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The cholesterol testing products market size is expected to increase from USD 23.57 billion in 2024 to USD 50.15 billion by 2034.

The cholesterol testing products market is expected to grow at a compound annual growth rate (CAGR) of around 7.84% from 2025 to 2034.

The major players in the cholesterol testing products market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation (Beckman Coulter), Thermo Fisher Scientific, Bio-Rad Laboratories, Randox Laboratories, Nova Biomedical, PTS Diagnostics, ACON Laboratories, Bioptik Technology Inc., Sekisui Diagnostics, F. Hoffmann-La Roche AG, Alere Inc. (now part of Abbott), ARKRAY Inc, Bayer AG, Jant Pharmacal Corporation, Trividia Health, Quest Diagnostics, and Laboratory Corporation of America (LabCorp).

The driving factors of the cholesterol testing products market are the rising prevalence of cardiovascular diseases, which is likely to boost the growth of the market during the forecast period.

North America region will lead the global cholesterol testing products market during the forecast period 2025 to 2034.